The endocrine and reproductive consequences of endotoxin-
mediated / inflammatory diseases
Prof. Huszenicza, GyulaDVM, PhD, DSc, Dipl. of ECAR
Szent István University,
Faculty of veterinary Science, Budapest
1) Endotoxin (LPS) / Peptidoglycans2) Pathophysiology (endocrine aspects)3) Consequences on reproductive functions:
• follicular growth / maturation, ovulation - during cyclicity - during the onset of cyclicity / at the expected time of
the 1st ovulation
• CL: - during cyclicity - in pregnants
• endotoxin ⇒ pregnancy • sow: MMA syndrome
The endocrine and reproductive conse-quences of inflammatory diseases
1) Endotoxin (LPS) / Peptidoglycans 2) Pathophysiology (endocrine aspects)3) Consequences on reproductive functions:
• follicular growth / maturation, ovulation - during cyclicity - during the onset of cyclicity / at the expected time of
the 1st ovulation
• CL: - during cyclicity - in pregnants
• endotoxin ⇒ pregnancy • sow: MMA syndrome
The endocrine and reproductive conse-quences of endotoxin-mediated diseases
(Sandholm and Pyorala, 1995)Initiation of inflamma-Initiation of inflamma-tory process:tory process: . Host (PMN leukocyte) -Host (PMN leukocyte) - . pathogen interactionpathogen interaction
Questions:Questions: What kind of What kind of mediatorsmediators??
What of the What of the bacterial compoundsbacterial compounds can induce can induce their production? their production?
Macrophage Macrophage
MonocyteMonocyte
Pathogens:Pathogens:
- - Gram-negative (GN) microbesGram-negative (GN) microbes: : endotoxin (LPS), ...endotoxin (LPS), ... - Gram-positive (GP) microbes: peptidoglycan,
(exo)toxins, ...
(Sandholm et al., 1995; Sordillo and Delay, 1995)
Bacterial compounds:Bacterial compounds:Gram-negativesGram-negatives
Endotoxin (LPS): cell wall structure of Gram-negative (GN) bacteria
(Sandholm and Pyorala, 1995)
Endotoxin (LPS): cell wall structure of Gram-negative (GN) bacteria
(Sandholm and Pyorala, 1995)
Liberated after the death of bacteria
Most / all of the invading pathogens have died by time of first clinical symptoms
Sources of endotoxin loading1) Gram-negative sepsis
2) Iatrogenic
3) Gastrointestinalis tract (forestomack, large intestine, … )
4) Organic diseases caused by Gram-negative bakteria: - uterus: (acut putrid) endometritis
- mammary gland: GN mastitis
- …
Sources of endotoxin loading
Endocrine/ reproductive / clinical consequences
Differences in absorption / detoxification
1) Gram-negative sepsis
2) Iatrogenic
3) Gastrointestinalis tract (forestomack, large intestine, … )
4) Organic diseases caused by Gram-negative bakteria: - uterus: (acut putrid) endometritis
- mammary gland: GN mastitis
- …
Macrophage Macrophage
MonocyteMonocyte
Pathogens:Pathogens:
- Gram-negative (GN) microbes: - Gram-negative (GN) microbes: endotoxin (LPS), ...endotoxin (LPS), ... - - Gram-positive (GP) microbesGram-positive (GP) microbes:: peptidoglycan,peptidoglycan,
(exo)toxins, ...(exo)toxins, ...
(Salyers and Whitt, 1994; Sordillo and Delay, 1995)
Bacterial compounds:Bacterial compounds:Gram-positivesGram-positives
Inflammatory Inflammatory mediatorsmediators
Oxygen radicalsOxygen radicals (nitric oxide, NO)(nitric oxide, NO)Eicosanoids Eicosanoids
(PG-s, leukotrienes, tromboxanes)(PG-s, leukotrienes, tromboxanes)
ProteinsProteins
(TNF(TNFαα , , interleukins)interleukins)
(after Sandholm and Pyorala, 1995)
„„Classical”Classical” (histamine, (histamine, serotonin, kinins, serotonin, kinins,
complements)complements)
(after Sandholm and Pyorala, 1995)
==
Inflammatory processInflammatory process
Local Local
General General }}
(after Sandholm and Pyorala, 1995)
==
symptomssymptomsMastitisMastitis
(Endo)metritis(Endo)metritis
OthersOthers
(Postpartum) (Postpartum) E. coliE. coli mastitis mastitis
- Direct endotoxin effect: - Direct endotoxin effect: << 24 h 24 h
- Absorption: only mediators (endotoxin ???)- Absorption: only mediators (endotoxin ???)
- Detoxification: alveolar epithel (+ liver, but: function ? - Detoxification: alveolar epithel (+ liver, but: function ? ))
- Coinciding bacteraemia: never- Coinciding bacteraemia: never
(after Sandholm and Pyorala, 1995)
Intensive Intensive LPS LPS cytokine cytokine release release
(Postpartum) (Postpartum) E. coliE. coli mastitis mastitis
- (Usually) severe clinical symptoms- (Usually) severe clinical symptoms
- Characteristic endocrine changes- Characteristic endocrine changes
(after Sandholm and Pyorala, 1995)
Intensive Intensive LPS LPS cytokine cytokine release release
(Postpartum) (Postpartum) S. aureusS. aureus mastitis mastitis
- Usually: exacerbation / relapse of chronic - Usually: exacerbation / relapse of chronic infections infections
- Clinical symptoms: may be severe / fatal- Clinical symptoms: may be severe / fatal
- Endocrine changes ???- Endocrine changes ???
(Sandholm et al., 1995)
CytokineCytokine release: may release: may be intensivebe intensive
(Postpartum) mastitis caused by other(Postpartum) mastitis caused by other GP GP (environmental) pathogens (Str. ssp)(environmental) pathogens (Str. ssp)
- Local symptoms:- Local symptoms: may vary may vary
- General symptoms: usually are not - General symptoms: usually are not severe / never fatal severe / never fatal
- Endocrine changes: ---- Endocrine changes: ---
(Sandholm et al., 1995)CytokineCytokine release: usually release: usually not intensivenot intensive
Endotoxin: (acut putrid) endometritis
- At least 2/3 - 5/7 days after parturition !
- Absorption: endotox. + mediators + other toxic compounds
- Detoxification: limited (⇐ way of absorption + liver function )
- Coincindingly: perhaps also bacteraemia
Endocrine consequences
of experimental
(iv/ipt) endotoxin
administration
Oxygen radicals Oxygen radicals (nitric oxide, NO)(nitric oxide, NO)Eicosanoids Eicosanoids
(PG-s, leukotrienes, tromboxanes)(PG-s, leukotrienes, tromboxanes)
ProteinsProteins
(TNF(TNFαα , , interleukins)interleukins)
(after Sandholm and Pyorala, 1995)„„Classical” Classical” (histamine, (histamine,
serotonin, kinins, serotonin, kinins, complements)complements)
==
Mediator-induced endocrine changesMediator-induced endocrine changes
Proteins:Proteins:
- - TNFTNFαα -- interleukinsinterleukins
ACTH ACTH ⇒⇒ cortisol cortisol
(+ progesterone (+ progesterone ) )
Prolactin Prolactin / /
TSH TSH ⇒⇒ T4 / T3 T4 / T3
GH GH / / ⇒⇒ IGF-1 IGF-1 + IGFBP-2 + IGFBP-2
Insulin Insulin glukagon glukagon
Leptin Leptin / / ∅∅ ? ?
(Hirvonen et al., 1999; Kakizaki et al., 1999; Soliman et al., 2002;
Lehtolainen et al., 2003; Waldron et al., 2003)
(Sandholm and Pyorala, 1995)
TNFTNFααIL-1IL-1
IL-6IL-6
ACTHACTH
GlucocorticoidsGlucocorticoids
Mediator-induced endocrine changesMediator-induced endocrine changes
Proteins:Proteins:
- - TNFTNFαα -- interleukinsinterleukins
ACTH ACTH ⇒⇒ cortisol cortisol
(+ progesterone (+ progesterone ))
Prolactin Prolactin / /
TSH TSH ⇒⇒ T4 / T3 T4 / T3
GH GH / / ⇒⇒ IGF-1 IGF-1 + IGFBP-2 + IGFBP-2
Insulin Insulin glukagon glukagon
Leptin Leptin / / ∅∅ ? ?
(Suzuki et al., 2001)
Mediator-induced endocrine changesMediator-induced endocrine changes
Proteins:Proteins:
- - TNFTNFαα -- interleukinsinterleukins
ACTH ACTH ⇒⇒ cortisol cortisol
(+ progesterone (+ progesterone ) )
Prolactin Prolactin
TSH TSH ⇒⇒ T4 / T3 T4 / T3
GH GH / / ⇒⇒ IGF-1 IGF-1 + IGFBP-2 + IGFBP-2
Insulin Insulin glukagon glukagon
Leptin Leptin / / ∅∅ ? ?
(Jackson et al., 1990)
Mediator-induced endocrine changesMediator-induced endocrine changes
Proteins:Proteins:
- - TNFTNFαα -- interleukinsinterleukins
ACTH ACTH ⇒⇒ cortisol cortisol
(+ progesterone (+ progesterone ) )
Prolactin (Prolactin (only in sowsonly in sows: : ) )
TSH TSH ⇒⇒ T4 / T3 T4 / T3
GH GH / / ⇒⇒ IGF-1 IGF-1 + IGFBP-2 + IGFBP-2
Insulin Insulin glukagon glukagon
Leptin Leptin / / ∅∅ ? ?
(Smith and Wagner, 1984 and 1985)
Mediator-induced endocrine changesMediator-induced endocrine changes
Proteins:Proteins:
- - TNFTNFαα -- interleukinsinterleukins
ACTH ACTH ⇒⇒ cortisol cortisol
(+ progesterone (+ progesterone ) )
Prolactin Prolactin / /
TSH TSH ⇒⇒ T4 / T3 T4 / T3
GH GH / / ⇒⇒ IGF-1 IGF-1 + IGFBP-2 + IGFBP-2
Insulin Insulin glukagon glukagon
Leptin Leptin / / ∅∅ ? ?
( Lab rodents / primates: Wartofsky and Burma, 1982; Haastaren et al., 1994;
Rettori at al., 1994; Bartalena et al., 1998; Bertók, 1998
Cattle: Kahl et al., 2000)
--
HThHTh
++
TSHTSH
TT44 ⇒⇒ T T33
--
DopaminDopaminTRHTRH
++
HELHEL
Production:Production: Only in severe casesOnly in severe cases
TNFα / IL-1: may
inhibit the TSH
release from the
pituitary cells
( Haastaren et al., 1994; Rettori at al., 1994; Hashimoto et al., 1998; Bertók, 1998 )
Johnson és Becker 1987;
Brabant és mtsai, 1991
Dupre és mtsai, 2004
--
HThHTh
++
TSHTSH
TT44 ⇒⇒ T T33
--
DopaminDopaminTRHTRH
++
HELHEL
Metabolism:Metabolism:
TT44 ⇒⇒ T T3 3
TT3 3 ⇒⇒ rTrT3 3
Outer-ring Outer-ring deiodination by deiodination by
type-I 5’Dtype-I 5’D
( Haastaren et al., 1994; Hashimoto et al., 1998; Kahl et al., 2000 )
InactivationInactivation
--
HThHTh
++
TSHTSH
TT44 ⇒⇒ T T33
--
DopaminDopaminTRHTRH
++
HELHEL
Metabolism:Metabolism:
TT44 ⇒⇒ T T3 3
TT3 3 ⇒⇒ rTrT3 3
InactivationInactivation
Plasma: Plasma: TT4 4
TT3 3
rTrT3 3
Production:Production: Only in Only in severe casessevere cases
Mediator-induced endocrine changesMediator-induced endocrine changes
Proteins:Proteins:
- - TNFTNFαα -- interleukinsinterleukins
ACTH ACTH ⇒⇒ cortisol cortisol
(+ progesterone (+ progesterone ) )
Prolactin Prolactin / /
TSH TSH ⇒⇒ T4 / T3 T4 / T3
GH GH / / ⇒⇒ IGF-1 IGF-1 + IGFBP-2 + IGFBP-2
Insulin Insulin glukagon glukagon
Leptin Leptin / / ∅∅ ? ?
( Lab rodents: Rettori et al., 1994
Cattle: Elsasser et al., 1995 and 1996; Briard et al., 2000; Nikolic et al., 2003;
Waldron et al., 2003)
Mediator-induced endocrine changesMediator-induced endocrine changes
Proteins:Proteins:
- - TNFTNFαα -- interleukinsinterleukins
ACTH ACTH ⇒⇒ cortisol cortisol
(+ progesterone (+ progesterone ) )
Prolactin Prolactin / /
TSH TSH ⇒⇒ T4 / T3 T4 / T3
GH GH / / ⇒⇒ IGF-1 IGF-1 + IGFBP-2 + IGFBP-2
Insulin Insulin glukagon glukagon
Leptin Leptin / / ∅∅ ? ?
(McMahon et al., 1998; Steigner et al., 1999; Koshibiki et al., 2000;
Soliman et al., 2002; Waldron et al., 2003)
Mediator-induced endocrine changesMediator-induced endocrine changes
Proteins:Proteins:
- - TNFTNFαα -- interleukinsinterleukins
ACTH ACTH ⇒⇒ cortisol cortisol
(+ progesterone (+ progesterone ) )
Prolactin Prolactin / /
TSH TSH ⇒⇒ T4 / T3 T4 / T3
GH GH / / ⇒⇒ IGF-1 IGF-1 + IGFBP-2 + IGFBP-2
Insulin Insulin glukagon glukagon
Leptin Leptin / / ∅∅ ? ?
(Lab rodents/primates: Bornstein et al., 1998; Mastronaldi et al., 2000;
Pig: Spurlock et al., 1998; Leininger et al., 2000;
Ruminants: Soliman et al., 2001 and 2002; Waldron et al., 2003)
Mediator-induced endocrine changesMediator-induced endocrine changes
Proteins:Proteins:
- - TNFTNFαα -- interleukinsinterleukins
( Metabolism: shifted catabolic direction Metabolism: shifted catabolic direction
(( Anorexia) Anorexia)
ACTH ACTH ⇒⇒ cortisol cortisol
(+ progesterone (+ progesterone ) )
Prolactin Prolactin / /
TSH TSH ⇒⇒ T4 / T3 T4 / T3
GH GH / / ⇒⇒ IGF-1 IGF-1 + IGFBP-2 + IGFBP-2
Insulin Insulin glukagon glukagon
Leptin Leptin / / ∅∅ ? ?
(Houseknecht et al., 1998;
Waldron et al., 2003)
1) Endotoxin (LPS). Sources of endotoxin ✔ 2) Pathophysiology (endocrine aspects) ✔ 3) Consequences on reproductive functions:
• follicular growth / maturation, ovulation - during cyclicity - during the onset of cyclicity / at the expected time of
the 1st ovulation
• CL: - during cyclicity - in pregnants
• endotoxin ⇒ pregnancy • sow: MMA syndrome
The endocrine and reproductive conse-quences of endotoxin-mediated diseases
THECA CELLS
OOCYTE
GRANULOSA CELLS
BASEMENT MEMBRANE
BLOOD VESSELS
Oocyte quality (?)Mechanisms:Mechanisms:
- TNF- TNFαα , IL-1, IL-6 , IL-1, IL-6 (others ?)(others ?)
- Catabolic and/or - Catabolic and/or endocrine changes?endocrine changes?
- Endotoxin ?- Endotoxin ?
- Fever (= heat ?)- Fever (= heat ?)
- Blood supply / - Blood supply / coagulation ?coagulation ?
… … ??
(Oliver et al., 2000)
THECA CELLS
OOCYTE
GRANULOSA CELLS
BASEMENT MEMBRANE
BLOOD VESSELS
ESTROGEN
Endocrine regula-tion / activity
FSH
LH (basal + preovul.)
- TNF- TNFαα , (IL-1, IL-6?), (IL-1, IL-6?)
(- Nitric oxide(- Nitric oxide
- Catabolic - Catabolic changes?)changes?)
(Rettori et al., 1994; Oliver et al., 2000;
Battaglia et al., 2000; Suzuki et al., 2001;
Daniel et al., 2002)
(Peter et al., 1989;
Lopez-Diaz and Bosu, 2002)
Endotoxin (prooestrus)
(Suzuki et al., Dom. Anim. Endocr., 2001. 20. 267-278.)
Progesterone(P4)
Animals:
- Cyclic heifers (24-38 mo, 480-540 kg)
- Treated: n = 6; Control: n = 6
Intravenous LPS loading:
- at 48 after a luteolytic dose of PGF2α
- with 5 µg/kg E. coli O111:B4 (Sigma)
17β-estradiol (E2)
Progesterone(P4)
Cortisol
Animals:Animals:
- Cyclic heifers (24-38 mo, 480-540 kg)- Cyclic heifers (24-38 mo, 480-540 kg)
- - Treated:Treated: n = 6; n = 6; Control:Control: n = 6 n = 6
Intravenous LPS loading:Intravenous LPS loading:
- at 48 after a luteolytic dose of PGF2- at 48 after a luteolytic dose of PGF2αα
- with 5 - with 5 µµ g/kg g/kg E. coli O111:B4 (Sigma)(Sigma)
Endotoxin Endotoxin (prooestrus)(prooestrus)
(Suzuki et al., Dom. Anim. Endocr., 2001. 20. 267-278.)
n
g/m
l
ng/
ml
pg/m
l
ControlControl
Minutes after LPSMinutes after LPS
(Suzuki et al.,
Dom. Anim. Endocr.,
2001. 20. 267-278.)
Treated Treated (Heifer 2)(Heifer 2)
Treated Treated (Heifer 1)(Heifer 1)
Treated Treated (Heifer 3)(Heifer 3)
Basal LHBasal LH (ng/ (ng/ml)ml)
ControlControl TreatedTreated
Hours after luteolytic dose of PGF2Hours after luteolytic dose of PGF2αα
Preovulatory LH peakPreovulatory LH peak
(Suzuki et al., Dom. Anim. Endocr., 2001. 20. 267-278.)
Milk: PMilk: P44
Estrus: exam.+AIEstrus: exam.+AI
30 60 80 95-100 30 60 80 95-100 dayday
Vagin. + RPVagin. + RP
Plasma: Plasma: metab.metab.
3x / week (2-3 d apart)3x / week (2-3 d apart)
Exp. 3Exp. 3:: ≥≥ 2nd parity cows in 4 herds (n=335 2nd parity cows in 4 herds (n=335 ⇒⇒ 263) 263) . If in If in prev. lactprev. lact.: .: chr. recurrent mastitis chr. recurrent mastitis ∅∅ (SCC<400 th/ml) (SCC<400 th/ml)
current lact.: acute putid (endo)metritis ∅
CalvingCalving
(Jánosi et al, Acta Vet. Hung., 2003;
Huszenicza et al., Repr. Dom. Anim., in press.)
Milk: PMilk: P44
Estrus: exam.+AIEstrus: exam.+AI
30 60 80 95-100 30 60 80 95-100 dayday
Vagin. + RPVagin. + RP
Plasma: Plasma: metab.metab.
3x / week (2-3 d apart)3x / week (2-3 d apart)
Exp. 3Exp. 3:: ≥≥ 2nd parity cows in 4 herds (n=335 2nd parity cows in 4 herds (n=335 ⇒⇒ 263) 263) . If in If in prev. lactprev. lact.: .: chr. recurrent mastitis chr. recurrent mastitis ∅∅ (SCC<400 th/ml) (SCC<400 th/ml)
current lactcurrent lact.: .: acute putid (endo)metritis acute putid (endo)metritis ∅∅
Clin. exam. + ScoringClin. exam. + Scoring
Sampling for bact. Sampling for bact.
CalvingCalving
(Jánosi et al, Acta Vet. Hung., 2003;
Huszenicza et al., Repr. Dom. Anim., in press.)
14 28 42 day14 28 42 day
AcycliaAcyclia
PP44, nmol/l, nmol/l
PP44, nmol/l, nmol/l
PP44, nmol/l, nmol/l≤≤ 28 day: 50 %28 day: 50 %aab
48 %48 %bba
22 %22 %abab
a-a, b-ba-a, b-bP<0.05P<0.05
32.032.0±±13.4 day13.4 dayaa
n=175n=175
33.433.4±±16.0 day16.0 day
n=59n=59
n=27n=27
GN + NDP !!!GN + NDP !!!38.638.6±±11.8 day11.8 dayaa
CalvingCalving
***P<0.001; ***P<0.001; a-a, b-ba-a, b-bP<0.001P<0.001
CalvingCalving 20 40 60 80 20 40 60 80 dayday
Mastitis Mastitis
Follicle phaseFollicle phase
+ Ovulation + Ovulation
GN+NDPGN+NDPGPGP
PP44, nmol/l, nmol/l
Foll. phase: Foll. phase: >10 day>10 day
AllAll 24 24 13 13 289289
Of them: Elongated*** Of them: Elongated*** 0 0 54 % 54 % 4 %4 %
⇒⇒ Estrus***Estrus*** 17 % 17 % 8 % 8 % 64 % 64 %
Follicular phase, dayFollicular phase, day 7.9 7.9±±0.60.6aa 10.8 10.8±±3.13.1abab 7.2 7.2±±0.80.8bb
Dominant Dominant follicle follicle (DF)(DF)
GN mastitisGN mastitis
Endotoxin Endotoxin .
cytokines+NOcytokines+NO
- 5 5 10 day day
PP44, nmol/l, nmol/l
Mastitis Mastitis ⇒⇒ folicular maturation / ovulation folicular maturation / ovulation
InterpretationInterpretation
DF-1 DF-2
GN mastitisGN mastitis
- 5 5 10 day day
PP44, nmol/l, nmol/l
??Endotoxin Endotoxin .
cytokines+NOcytokines+NO
Dominant Dominant follicle follicle (DF)(DF)
Mastitis Mastitis ⇒⇒ folicular maturation / ovulation folicular maturation / ovulation
DF-1 DF-2
GN mastitisGN mastitis
CL
Ovulation Ovulation ⇒⇒ CL CL
- 5 5 10 day- 5 5 10 day
PP44, nmol/l, nmol/l
Dominant Dominant follicle follicle (DF)(DF)
Mastitis Mastitis ⇒⇒ folicular maturation / ovulation folicular maturation / ovulation
Endotoxin Endotoxin .
cytokines+NOcytokines+NO
DF-1 DF-2
GN mastitisGN mastitis
CL
Ovulation Ovulation ⇒⇒ CL CL
- 5 5 10 day- 5 5 10 day
PP44, nmol/l, nmol/l
Dominant Dominant follicle follicle (DF)(DF)
Endotoxin Endotoxin .
cytokines+NOcytokines+NO
Mastitis Mastitis ⇒⇒ folicular maturation / ovulation folicular maturation / ovulation (in acyclic cows)(in acyclic cows)
DF-1 DF-2
GN mastitisGN mastitis
CL
Ovulation Ovulation ⇒⇒ CL CL
Mastitis Mastitis ⇒⇒ folicular maturation / ovulation folicular maturation / ovulation (in cyclic cows)(in cyclic cows)
- 5 5 10 day- 5 5 10 day
PP44, nmol/l, nmol/l
Endotoxin Endotoxin .
cytokines+NOcytokines+NO
Dominant Dominant follicle follicle (DF)(DF)
0
1
2
3
0Calving
15 30 45 60 75 90Day
Cessation of cyclicity
Secondaryacyclicity: >21 days
RP/US:
0
1
2
3
0Calving
15 30 45 60 75 90Day
Short-lived (<10 days) CL
(sCL)
0
1
2
3
0Calving
15 30 45 60 75 90
Acyclicity: > 35-45 days
Negative energy balance, baseline LH pulsatility and 1st ovulation
Energy
balance (EB)
-5 0 +5 + 10
Days relative to the nadir of negative EB
1st ovulation
(Butler et al., 1981; Butler and Smith, 1989 ; Butler, 2000)
Mastitis: can/may override this mechanism (LPS / cytokines ⇒ follicular maturation / ovulation)
Energy
balance (EB)
-5 0 +5 + 10
Days relative to the nadir of negative EB
1st ovulation+ 7-10 days
0
1
2
3
0Calving
15 30 45 60 75 90
Acyclicity: > 35-45 days
0
1
2
3
0Calving
15 30 45 60 75 90Day
Short-lived (<10 days) CL
(sCL)
0
1
2
3
0Calving
15 30 45 60 75 90Day
Cessation of cyclicity
Secondaryacyclicity: >21 days
RP/US:
Presence of anovulatory cysts
Diagnosed : by (repeated) rectal palpationSize : > 25 mmPresent : for > 7-14 daysSimultaneously : no regular cyclicity / CL
Presence of anovulatory cysts
0
5
10
15
20
25
E.coliinfected
Notinfected
On days 28-35: E. coli
P<0.05
%
0
5
10
15
20
25
A. p
yo
ge
ne
s
A. p
yo
+ G
N-
an
ae
rob
s
GN
-an
ae
rob
s
No
ute
rin
ep
ath
.
On days 28-35: A. pyogenes and /or GN anaerobs
%
0
5
10
15
20
25
APE No APE
On days <14:acute putrid endometritis
%
1) Endotoxin (LPS). Sources of endotoxin ✔ 2) Pathophysiology (endocrine aspects) ✔ 3) Consequences on reproductive functions:
• follicular growth / maturation, ovulation ✔ - during cyclicity ✔ - during the onset of cyclicity / at the expected time of
the 1st ovulation ✔
• CL: - during cyclicity - in pregnants
• endotoxin ⇒ pregnancy • sow: MMA syndrome
The endocrine and reproductive conse-quences of endotoxin-mediated diseases
Oxygen radicals Oxygen radicals (nitric oxide, NO)(nitric oxide, NO)Eicosanoids Eicosanoids
(PG-s, leukotrienes, tromboxanes)(PG-s, leukotrienes, tromboxanes)
Proteins Proteins
(TNF(TNFαα , , interleukins)interleukins)
(after Sandholm and Pyorala, 1995)„„Classical” Classical” (histamine, (histamine,
serotonin, kinins, serotonin, kinins, complements)complements)
==
Corpus luteumCorpus luteum
Eicosanoids:Eicosanoids:
- PG-s incl. - PG-s incl. PGF2PGF2αα
- leukotrienes- leukotrienes
- tromboxanes- tromboxanes
PGF2PGF2αα
Induced Induced luteolysis?luteolysis?
(Metritis: Peter and Bosu, 1987; Peter et al., 1987; Giri et al., 1990;
Gilbert et al., 1990; Kindahl et al., 1996)
Corpus luteumCorpus luteum
Eicosanoids:Eicosanoids:
- PG-s incl. - PG-s incl. PGF2PGF2αα
- leukotrienes- leukotrienes
- tromboxanes- tromboxanes
PGF2PGF2αα
Induced Induced luteolysis?luteolysis?
Also in Gram-positive infection !
Prostanoids / PG F2alfa
PGFPGF22αα
Induced Induced luteolysis?luteolysis?
Way of mediators to ovary
???
Systemic way
Utero-ovarian vascular Utero-ovarian vascular countercurrent diffusion countercurrent diffusion systemsystem
Oxytocin induced PGFM response in experimental
(Str. uberis) mastitis Animals:
Cows with no IMI on d ≈ 30 post- partum, in the CL phase
Experimental intramammary (IMI) infection:
With 5 ml of 5.05 x103 CFU µg/kg encapsulated S. uberis susp.
(Hockett et al., Anim. Reprod. Sci., 2000. 58. 241-251.) .
Treated: n = 5Control: n = 5
100 IU oxytocin (on d 4
postinf.)
Prostanoids / PG F2alfaSystemic way
Utero-ovarian vascular Utero-ovarian vascular countercurrent diffusion countercurrent diffusion systemsystem
Hypothetic model
Induced Induced luteolysis?luteolysis?
???
PGFPGF22αα
TNFTNFαα
(after Okuda et al., 2002)
Prostanoids / PG F2alfa
… in accordance with LPS administration in cattle ...
Induced luteolysis:Induced luteolysis:
in cyclic cows: >4 d in cyclic cows: >4 d
in pregnants: in pregnants: < ≈ 90-120 d ???
PGFPGF22αα
TNFTNFαα
(Kindahl et al., 1996)
Systemic way
Utero-ovarian vascular Utero-ovarian vascular countercurrent diffusion countercurrent diffusion systemsystem
1) Endotoxin (LPS) / Peptidoglycans ✔2) Pathophysiology (endocrine aspects) ✔ 3) Consequences on reproductive functions:
• follicular growth / maturation, ovulation ✔ - during cyclicity ✔ - during the onset of cyclicity / at the expected time of
the 1st ovulation ✔
• CL: - during cyclicity - in pregnants
• endotoxin ⇒ pregnancy • sow: MMA syndrome
The endocrine and reproductive conse-quences of endotoxin-mediated diseases
***P<0.001; ***P<0.001; a-a, b-ba-a, b-bP<0.001P<0.001
CalvingCalving 20 40 60 80 20 40 60 80 dayday
GN+NDPGN+NDPGPGP
sCL: sCL: <10 day<10 day
Mastitis Mastitis
CL CL szőérés
+ Ovuláció
AllAll 24 24 30 30 211211
Of them: Luteolysis / sCL*** Of them: Luteolysis / sCL*** 8 % 8 % 47 % 47 % 4 %4 %
⇒⇒ Estrus***Estrus*** 0 0 7 % 7 % 62 % 62 %
CL phase, dayCL phase, day 16.9 16.9±±3.53.5aa 13.1 13.1±±4.54.5abab 17.1 17.1±±2.52.5bb
PP44, nmol/l, nmol/l
0
1
2
3
0Calving
15 30 45 60 75 90
Acyclicity: > 35-45 days
0
1
2
3
0Calving
15 30 45 60 75 90Day
Cessation of cyclicity
Secondaryacyclicity: >21 days
RP/US:
0
1
2
3
0Calving
15 30 45 60 75 90Day
Short-lived (<10 days) CL
(sCL)
Endotoxin-induced luteolysis in cyclic females
Day after ovulation
Cattle: > 4th
Sheep: > 4th
Goat: > 4th
Horse: > 5th
Pig: > 13th
(Domestic carnivores: ??? )
1) Endotoxin (LPS) / Peptidoglycans ✔ 2) Pathophysiology (endocrine aspects) ✔ 3) Consequences on reproductive functions:
• follicular growth / maturation, ovulation ✔ - during cyclicity ✔ - during the onset of cyclicity / at the expected time of
the 1st ovulation ✔
• CL: - during cyclicity ✔ - in pregnants
• endotoxin ⇒ pregnancy • sow: MMA syndrome
The endocrine and reproductive conse-quences of endotoxin-mediated diseases
Endotoxin-induced luteolysis in pregnant females
Day after conception
Cattle: < ≈ 90-120th
Sheep: < ≈ 50th
Goat: all time of pregnancy
Horse: < ≈ 35 - 40th
Pig: < ≈ 80th
(Domestic carnivores: ??? )
1) Endotoxin (LPS) / Peptidoglycans ✔ 2) Pathophysiology (endocrine aspects) ✔ 3) Consequences on reproductive functions:
• follicular growth / maturation, ovulation ✔ - during cyclicity ✔ - during the onset of cyclicity / at the expected time of
the 1st ovulation ✔
• CL: - during cyclicity ✔ - in pregnants
• endotoxin ⇒ pregnancy • sow: MMA syndrome
The endocrine and reproductive conse-quences of endotoxin-mediated diseases
Endotoxin-mediated diseases /pregnancy
- CLpregn.
- Other effects: • cortisol • placenta• embryo foetus
1) Endotoxin (LPS) / Peptidoglycans ✔ 2) Pathophysiology (endocrine aspects) ✔ 3) Consequences on reproductive functions:
• follicular growth / maturation, ovulation ✔ - during cyclicity ✔ - during the onset of cyclicity / at the expected time of
the 1st ovulation ✔
• CL: - during cyclicity ✔ - in pregnants ✔
• endotoxin ⇒ pregnancy ✔ • sow: MMA syndrome
The endocrine and reproductive conse-quences of endotoxin-mediated diseases
Sow: agalactia
Endotoxin-induced inflammatory changes and their endocrine consequences
Proteins:
TNFα interleucins
ACTH ⇒ cortisol
(progesterone )
TSH, T4 / T3; prolactin
(GH-induced) IGF-1 prod.
Insulin / ? Leptin ?
Thanks for Thanks for
your your
honoring honoring
attention ..attention ..
..